Game-changing obesity drugs go mainstream: what scientists are learning

NEWS 23 May 2023 Game-changing obesity drugs go mainstream: what scientists are learning Studies tackle who’s most likely to lose weight on the new generation of anti-obesity medications. By

Mariana Lenharo Mariana Lenharo View author publications You can also search for this author in PubMed  Google Scholar

Twitter Facebook Email Access through your institution Buy or subscribe A new generation of drugs is revolutionizing the treatment of obesity and astonishing researchers with their potency.

The drug semaglutide, for example, enabled one-third of clinical-trial participants to shed at least 20% of their body weight1. Tirzepatide, a competing therapy, achieved similar results in

more than half of study participants2.

customer support

Nature 618, 17-18 (2023)

doi: https://doi.org/10.1038/d41586-023-01712-8

References Wilding, J. P. H. et al. N. Engl. J. Med. 384, 989–1002 (2021).

Article  PubMed  Google Scholar 

Jastreboff, A. M. et al. N. Engl. J. Med. 387, 205–216 (2022).

Article  PubMed  Google Scholar 

Acosta, A. et al. Obesity 29, 662–671 (2021).

Article  PubMed  Google Scholar 

Jensterle, M. et al. Endocr. Abstr. 81, OC5.2 (2022).

Article  Google Scholar 

Rubino, D. et al. JAMA 325, 1414–1425 (2021).

Article  PubMed  Google Scholar 

Download references

Reprints and permissions

Related Articles The ‘breakthrough’ obesity drugs that have stunned researchers

The vicious cycle of depression and obesity

The sting of sizeism in the scientific workplace

Common sweetener suppresses mouse immune system — in high doses

Subjects Obesity Medical research Metabolism Latest on: Obesity Mice lacking this amino acid lost 30% of their body weight

News 21 MAY 25

How much ultra-processed food do you eat? Blood and urine record it

News 20 MAY 25

Losing weight through better sleep

Outlook 09 APR 25

Medical research Medicine’s rapid adoption of AI has researchers concerned

News 09 JUN 25

Sticky membranes of dead red blood cells obstruct small vessels

News & Views 04 JUN 25

Y-chromosome loss in cancer and immune cells might worsen treatment outcomes

News & Views 04 JUN 25

Metabolism Unravelling cysteine-deficiency-associated rapid weight loss

Article 21 MAY 25

Mice lacking this amino acid lost 30% of their body weight

News 21 MAY 25

How much ultra-processed food do you eat? Blood and urine record it

News 20 MAY 25

Jobs Post-Doctoral Fellowship in Regenerative Biology and Medicine (Lab of. Dr. Yuval Rinkevich) Discovery of cellular and molecular mechanisms of tissue repair and regeneration.

Beijing, China

The Chinese Institutes for Medical Research (CIMR), Beijing

Tenure-track Assistant Professor towards Associate Professor in the field of metabolic diseases UNIL is a leading international teaching and research institution, with over 5,000 employees

and 15,500 students split between its Dorigny campus, ...

Lausanne, Canton of Vaud (CH)

University of Lausanne (UNIL)

Associate or Senior Editor (Nature Structural & Molecular Biology and Nature Communications) Job Title: Associate or Senior Editor (Nature Structural & Molecular Biology and Nature

Communications)  Location: New York, Shanghai, Beijing, Mad...

New York City, New York (US)

Springer Nature Ltd

Postdoctoral Associate – Nima Sharifi Laboratory The Nima Sharifi Laboratory is seeking to recruit outstanding postdoctoral associates with a primary interest in the fundamental mechanisms

of huma...

Miami, Florida (US)

University of Miami Desai Sethi Urology Institute

Associate or Senior Editor, BMC Medicine Job Title: Associate or Senior Editor, BMC Medicine Location(s): Shanghai – Hybrid working model Application Deadline: June 25th, 2025   About

Spri...

Shanghai – Hybrid working model

Springer Nature Ltd